tradingkey.logo
搜索

NRX Pharmaceuticals Inc

NRXP
添加自选
3.150USD
+0.030+0.96%
收盘 07-31 16:00美东报价延迟15分钟
105.43M总市值
亏损市盈率 TTM

NRXP 财务数据

通过专为投资者打造的一站式数据看板,全面查看 NRX Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

NRX Pharmaceuticals Inc财报日历

最新发布
5月 15, 2026
每股收益 / 预测值
-0.04/0.29
营业收入 / 预测值
1.07M/25.57M
报告期
FY2025 财报
营业收入(YoY)
1.23M
--
每股收益(YoY)
-1.34
43.34%
分析师评级
BUY
2026/08/01
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
86.83%-0.04
101.68%0.01
-79.13%-0.26
-30.56%-0.98
95.45%-0.34
-37.75%-0.74
80.01%-0.15
36.93%-0.75
-350.62%-7.37
65.09%-0.54
45.88%-0.74
---1.19
---1.64
---1.54
---1.37
----
----
----
----
----
营业收入
--1.07M
--983.00K
--242.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
净利润
74.06%-1.43M
103.97%360.00K
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
-109.12%-9.08M
73.23%-1.62M
9.41%-7.90M
40.86%-6.53M
57.61%-4.34M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
66.74%-10.24M
75.48%-9.08M
97.27%-6.98M
-1404.73%-13.45M
-2731.67%-30.79M
-29355.90%-37.05M
-171095.97%-255.94M
利润率
---133.90%
--36.62%
---2433.88%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
毛利率
--35.02%
--54.22%
--49.17%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
资产负债率
----
-100.00%0.00%
-55.11%67.09%
29.54%211.49%
-38.18%110.63%
43.84%180.14%
94.60%149.46%
154.81%163.26%
219.78%178.96%
207.18%125.24%
--76.80%
--64.07%
--55.96%
--40.77%
--0.00%
----
----
----
----
----
营业收入
--1.07M
--983.00K
--242.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
营业利润
-26.71%-4.75M
-26.42%-4.59M
-36.27%-4.12M
47.09%-3.73M
37.53%-3.75M
17.52%-3.63M
47.97%-3.02M
11.19%-7.05M
36.43%-6.00M
55.44%-4.41M
36.46%-5.81M
17.31%-7.94M
39.92%-9.44M
81.33%-9.89M
54.52%-9.14M
43.91%-9.60M
-6566.53%-15.71M
-11999.79%-52.98M
-11791.02%-20.10M
-9343.29%-17.12M
净利润
74.06%-1.43M
103.97%360.00K
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
-109.12%-9.08M
73.23%-1.62M
9.41%-7.90M
40.86%-6.53M
57.61%-4.34M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
66.74%-10.24M
75.48%-9.08M
97.27%-6.98M
-1404.73%-13.45M
-2731.67%-30.79M
-29355.90%-37.05M
-171095.97%-255.94M
流动资产
1.45%7.36M
169.29%8.89M
190.96%11.95M
-5.94%4.59M
116.79%7.26M
-52.03%3.30M
-68.63%4.11M
-75.34%4.88M
-84.62%3.35M
-73.31%6.88M
-47.22%13.09M
-38.95%19.79M
-50.08%21.76M
-21.15%25.80M
-45.17%24.80M
74.89%32.41M
72875.69%43.58M
39573.53%32.71M
46483.52%45.23M
50259.98%18.53M
流动负债总额
-23.13%25.18M
30.71%28.58M
99.98%40.59M
71.01%40.45M
73.68%32.75M
14.78%21.86M
5.03%20.30M
4.59%23.66M
-14.53%18.86M
22.22%19.05M
140.33%19.33M
219.40%22.62M
85.22%22.06M
30.71%15.59M
-78.13%8.04M
-87.75%7.08M
1750.57%11.91M
1856.16%11.92M
9596.59%36.77M
19346.26%57.80M
总资产
56.82%11.90M
254.86%12.96M
236.08%15.00M
-8.09%4.84M
100.37%7.59M
-50.09%3.65M
-65.96%4.46M
-73.43%5.26M
-82.61%3.79M
-71.66%7.32M
-47.19%13.11M
-38.92%19.81M
-50.05%21.78M
-21.12%25.82M
-45.14%24.82M
74.87%32.43M
623.34%43.60M
440.94%32.73M
650.20%45.25M
195.47%18.55M
总负债
-21.47%25.72M
7.51%28.89M
75.02%40.75M
71.01%40.45M
73.68%32.75M
41.09%26.87M
20.47%23.28M
4.59%23.66M
-14.53%18.86M
3.48%19.05M
140.33%19.33M
219.40%22.62M
85.22%22.06M
54.38%18.41M
-78.13%8.04M
-87.86%7.08M
147.77%11.91M
202.87%11.92M
1199.01%36.77M
2099.87%58.31M
总权益
45.09%-13.82M
31.37%-15.94M
-36.83%-25.75M
-93.65%-35.62M
-66.97%-25.16M
-97.93%-23.22M
-202.75%-18.82M
-554.95%-18.39M
-5205.99%-15.07M
-258.36%-11.73M
-137.05%-6.22M
-111.08%-2.81M
-100.90%-284.00K
-64.39%7.41M
97.87%16.78M
163.75%25.35M
2497.37%31.69M
884.31%20.81M
164.93%8.48M
-1196.66%-39.77M
经营净额
-23.42%-4.29M
-76.98%-3.71M
-25.37%-2.89M
-57.22%-4.03M
5.20%-3.48M
34.27%-2.10M
49.47%-2.31M
67.20%-2.56M
39.71%-3.67M
61.63%-3.19M
27.16%-4.56M
47.18%-7.81M
41.34%-6.09M
26.26%-8.32M
47.85%-6.27M
-3.95%-14.79M
-5702.25%-10.38M
-4867.85%-11.28M
-18479.47%-12.01M
-6074.35%-14.23M
投资净额
---213.00K
---249.00K
---2.56M
----
--0.00
-100.00%0.00
100.00%0.00
-100.00%0.00
100.00%0.00
0.00%1.00K
60.00%-2.00K
166.67%2.00K
-33.33%-4.00K
357.73%1.00K
-30.58%-5.00K
-7.80%-3.00K
---3.00K
98.83%-388.00
-101.25%-3.83K
88.02%-2.78K
融资净额
-54.86%3.42M
141.42%4.58M
373.52%9.73M
-55.75%1.39M
1820.25%7.58M
269.80%1.90M
236.84%2.05M
-49.93%3.14M
-84.48%395.00K
-111.03%-1.12M
-5260.71%-1.50M
829.42%6.27M
-88.93%2.54M
819495.14%10.12M
-100.07%-28.00K
-103.34%-860.00K
12762.28%22.98M
-99.44%1.24K
18722.63%37.52M
14797.88%25.76M

常见问题

NRX Pharmaceuticals Inc的总收入是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,总收入达到了1.23M(同比变化1.23M)。

NRX Pharmaceuticals Inc的流动资产是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,流动资产为8.89M(同比变化169.29)。

NRX Pharmaceuticals Inc的总资产是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,NRX Pharmaceuticals Inc的总资产为12.96M(同比变化254.86)。

NRX Pharmaceuticals Inc的总负债是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,NRX Pharmaceuticals Inc的总负债为28.89M(同比变化7.51)。

NRX Pharmaceuticals Inc的总权益是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,NRX Pharmaceuticals Inc的总权益为-15.94M(同比变化31.37)。

NRX Pharmaceuticals Inc的净营业收入是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,NRX Pharmaceuticals Inc的净营业收入为-16.19M(同比变化17.84)。

NRX Pharmaceuticals Inc的净融资是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,NRX Pharmaceuticals Inc的净融资为23.28M(同比变化210.97)。

NRX Pharmaceuticals Inc的每股收益(EPS)是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.34(同比变化43.34)。

NRX Pharmaceuticals Inc的净利润是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,净利润为-28.62M(同比变化-13.91)。

NRX Pharmaceuticals Inc的资产回报率(ROA)是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-344.70(同比变化24.78)。

NRX Pharmaceuticals Inc的营业利润是多少?

根据NRX Pharmaceuticals Inc的FY2025财报,营业利润为-16.19M(同比变化17.84)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有